GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shijiazhuang Yiling Pharmaceutical Co Ltd (SZSE:002603) » Definitions » EPS without NRI

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) EPS without NRI : ¥0.30 (TTM As of Mar. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Shijiazhuang Yiling Pharmaceutical Co EPS without NRI?

Shijiazhuang Yiling Pharmaceutical Co's earnings per share without non-recurring items for the three months ended in Mar. 2024 was ¥0.18. Its earnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.30.

During the past 12 months, Shijiazhuang Yiling Pharmaceutical Co's average earnings per share (NRI) Growth Rate was -84.10% per year. During the past 3 years, the average earnings per share (NRI) Growth Rate was 2.60% per year. During the past 5 years, the average earnings per share (NRI) Growth Rate was 27.40% per year. During the past 10 years, the average earnings per share (NRI) Growth Rate was 20.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using Earnings per share without Non-Recurring Items (NRI) data.

The historical rank and industry rank for Shijiazhuang Yiling Pharmaceutical Co's EPS without NRI or its related term are showing as below:

SZSE:002603' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -25.4   Med: 10.9   Max: 61.7
Current: 2.6

During the past 13 years, Shijiazhuang Yiling Pharmaceutical Co's highest 3-Year average Earnings Per Share (NRI) Growth Rate was 61.70% per year. The lowest was -25.40% per year. And the median was 10.90% per year.

SZSE:002603's 3-Year EPS without NRI Growth Rate is ranked worse than
59.95% of 844 companies
in the Drug Manufacturers industry
Industry Median: 9.1 vs SZSE:002603: 2.60

Shijiazhuang Yiling Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was ¥0.18. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.27.

Shijiazhuang Yiling Pharmaceutical Co's EPS (Basic) for the three months ended in Mar. 2024 was ¥0.18. Its EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥0.27.


Shijiazhuang Yiling Pharmaceutical Co EPS without NRI Historical Data

The historical data trend for Shijiazhuang Yiling Pharmaceutical Co's EPS without NRI can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shijiazhuang Yiling Pharmaceutical Co EPS without NRI Chart

Shijiazhuang Yiling Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS without NRI
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.33 0.70 0.76 1.39 0.76

Shijiazhuang Yiling Pharmaceutical Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EPS without NRI Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.72 0.24 0.09 -0.20 0.18

Competitive Comparison of Shijiazhuang Yiling Pharmaceutical Co's EPS without NRI

For the Drug Manufacturers - Specialty & Generic subindustry, Shijiazhuang Yiling Pharmaceutical Co's PE Ratio without NRI, along with its competitors' market caps and PE Ratio without NRI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shijiazhuang Yiling Pharmaceutical Co's PE Ratio without NRI Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Shijiazhuang Yiling Pharmaceutical Co's PE Ratio without NRI distribution charts can be found below:

* The bar in red indicates where Shijiazhuang Yiling Pharmaceutical Co's PE Ratio without NRI falls into.



Shijiazhuang Yiling Pharmaceutical Co EPS without NRI Calculation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Earnings Per Share without Non-Recurring Items is the amount of earnings without non-recurring items per outstanding share of the company's stock.

EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0.30

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Shijiazhuang Yiling Pharmaceutical Co  (SZSE:002603) EPS without NRI Explanation

EPS without NRI removes onetime and unusual items from EPS, to provide investors with a more accurate measure of the company’s true earnings. The earnings are adjusted for items that are irregular or unusual in nature, and/or are non-recurring. This is calculated using Net Income (Continuing Operations) plus/minus any tax affected unusual Items and Goodwill Impairments/Write Offs. This can be used to fairly measure a company's profitability.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Shijiazhuang Yiling Pharmaceutical Co EPS without NRI Related Terms

Thank you for viewing the detailed overview of Shijiazhuang Yiling Pharmaceutical Co's EPS without NRI provided by GuruFocus.com. Please click on the following links to see related term pages.


Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Business Description

Traded in Other Exchanges
N/A
Address
No. 7 Tianfu street, Biology and medicine industrial base, Huangcun town, Daxing district, Beijing, CHN
Shijiazhuang Yiling Pharmaceutical Co Ltd is a China-based company engages in the pharmaceutical manufacturing. The company is principally engaged in the research, development, manufacturing, and sales of traditional Chinese pharmaceutical products, especially in the fields of cardiovascular and cerebrovascular diseases, respiratory diseases, tumor, diabetes and related complications. Its products include innovative drug series, chemical drugs, Chinese medicine series, and health products.
Executives
Zhang Qiu Lian Directors, executives
Han Yue Zhi Executives
Zhao Shao Hua Executives
Wang Wei Executives
Gao Xue Dong Supervisors
Wu Yi Ling Director
Gao Xiu Qiang Executives
Wu Xiang Jun Directors, executives
Guo Shuang Geng Director
Wang Hua Securities Affairs Representative
Dai Feng Xiang Directors, executives
Liu Gen Wu Supervisors
Wang Wei Ping Directors, executives
Xu Wei Dong Director
Wu Rui Directors, executives

Shijiazhuang Yiling Pharmaceutical Co (SZSE:002603) Headlines

No Headlines